Comparison of glycemic variations in Japanese patients with type 2 diabetes, between metformin high dose group and combination of metformin and sitagliptin or linagliptin group as assessed by continuous glucose monitoring (CGM) - Comparison of glycemic variations in T2D, between metformin highdose group and combination of metformin and sitagliptin or linagliptin group as assessed by CGM

Jikei University School of Medicine0 个研究点目标入组 25 人开始时间: 2015年9月17日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with type 1 diabetes 2)Patients with insulin therapy 3)Patients who take oral hypoglycemic agent other than metformin 4)Patients with severe acidosis or diabetic coma 5)Patients with infections, before and after surgery,and severe trauma 6)Patiens with severe liver disease 7)Patients with severe renal disease with a serum creatinine (Cr) level (mg/dL) >1.5 8)Patients with shock, heart disease (heart failure, myocardial infarction, pulmonary embolism), severe lung failure 9)Patients with malnutrition, starvation, debilitating condition, pituitary dysfunction, adrenal insufficiency 10)Patients have history of lactic acidosis 11)Heavy drinkers 12)Patients with dehydration, gastrointestinal disorders (diarrhea, vomiting,etc) 13)Cancer patients 14)Patients for the biguanide drug with a history of allergy, or with a history of other drug allergy 15)Potential pregnant patients or patient with who are breast feeding

发起方